Somewhat surprisingly, these studies showed that CRISPR/Cas9-mediated removal of SOS2 also caused some reduction of tumor burden and percentage of Ki67-positive and pERK-positive cells in the tumoral masses (Fig. 6b–e). The gene discussed is EIF2AK3; the disease is neoplasm.